TRETINOIN
ANTINEOPLASTIC - TRETINOIN · ACUTE PROMYELOCYTIC LEUKEMIA
PAR HEALTH USA,
Drug class
Antineoplastic - Tretinoin
The phrase "Antineoplastic - Tretinoin" reflects a drug-specific administrative categorization rather than a distinct multi-agent pharmacological class, specifically designating the antineoplastic use of the active pharmaceutical ingredient tretinoin (all-trans retinoic acid). Read more about Antineoplastic - Tretinoin
7 drugs in this class 6 manufacturers
Drugs in Antineoplastic - Tretinoin
TRETINOIN
ANTINEOPLASTIC - TRETINOIN · ACUTE PROMYELOCYTIC LEUKEMIA
GLENMARK PHARMA
TRETINOIN
ANTINEOPLASTIC - TRETINOIN · ACUTE PROMYELOCYTIC LEUKEMIA
TEVA USA
TRETINOIN (CHEMOTHERAPY) (tretinoin)
ANTINEOPLASTIC - TRETINOIN · ACUTE PROMYELOCYTIC LEUKEMIA
Major Pharamceuticals
TRETINOIN
ANTINEOPLASTIC - TRETINOIN · ACUTE PROMYELOCYTIC LEUKEMIA
Major Pharamceuticals
TRETINOIN
ACNE PRODUCTS · ACNE VULGARIS
BRYANT RANCH PR
TRETINOIN
ANTINEOPLASTIC - TRETINOIN · ACUTE PROMYELOCYTIC LEUKEMIA
AHP
Filter & compare in the drug finder →
Opens the drug finder with Antineoplastic - Tretinoin preselected. Add indication or manufacturer filters there.
The phrase "Antineoplastic - Tretinoin" reflects a drug-specific administrative categorization rather than a distinct multi-agent pharmacological class, specifically designating the antineoplastic use of the active pharmaceutical ingredient tretinoin (all-trans retinoic acid).
Pharmacologically classified as a first-generation retinoid and differentiation agent, systemic tretinoin binds to retinoic acid nuclear receptors to induce the terminal differentiation and subsequent apoptosis of malignant promyelocytes bearing the PML-RARa fusion protein.
Clinically, oral tretinoin serves as a core component of remission-induction and consolidation therapy for acute promyelocytic leukemia, distinguishing this oncologic formulation from topical dermatologic preparations.
-
nih.gov
The phrase "Antineoplastic - Tretinoin" reflects a drug-specific administrative categorization rather than a distinct multi-agent pharmacological class, specifically designating the antineoplastic use of the active pharmaceutical ingredient tretinoin (all-trans retinoic acid) Clinically, oral tretinoin serves as a core component of remission-induction and consolidation therapy for acute promyelocytic leukemia, distinguishing this oncologic formulation from topical dermatologic preparations
-
connectrx.com
The phrase "Antineoplastic - Tretinoin" reflects a drug-specific administrative categorization rather than a distinct multi-agent pharmacological class, specifically designating the antineoplastic use of the active pharmaceutical ingredient tretinoin (all-trans retinoic acid)
-
imimg.com
The phrase "Antineoplastic - Tretinoin" reflects a drug-specific administrative categorization rather than a distinct multi-agent pharmacological class, specifically designating the antineoplastic use of the active pharmaceutical ingredient tretinoin (all-trans retinoic acid) Pharmacologically classified as a first-generation retinoid and differentiation agent, systemic tretinoin binds to retinoic acid nuclear receptors to induce the terminal differentiation and subsequent apoptosis of malignant...
-
medic.co.il
Clinically, oral tretinoin serves as a core component of remission-induction and consolidation therapy for acute promyelocytic leukemia, distinguishing this oncologic formulation from topical dermatologic preparations
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.